Actelion is an independent, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs. ... Actelion is a global, independent ...

Actelion is an independent, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs. ...

However, Actelion Pharmaceuticals Ltd aims to ensure that such third parties provide the same degree of protection as Actelion Pharmaceuticals Ltd does and, where ...

Capsule info for Actelion Ltd. ... Need more? Get unbiased, in-depth information on public and private companies worldwide.

Find financial news, press releases and podcasts for Actelion Ltd Allschwil (ALIOF) on Boston.com

Find updated stock quotes and stock news for Actelion Ltd Allschwil (ALIOF) on Boston.com ... RESTORA Program to Confirm Efficacy and Safety in Patients Suffering From Primary ...

Source: Actelion Ltd. Actelion Announces Full Year 2006 Financial Results-- Total net revenue up 43% to CHF 945.7 million -- Tracleer(r) sales up 42% to CHF 898.7 million ...

Source: Actelion Ltd. Actelion Ltd.: Annual General Meeting of Shareholders in Basel, Switzerland. ALLSCHWIL/BASEL, Switzerland, May 4, 2007 (PRIME NEWSWIRE) -- At today's Annual ...

Start research for Actelion Ltd ATLN.VX stock data, including stock quotes, stock trading and stock prices at Reuters.com. Read Actelion Ltd ATLN.VX news, press release and ...

Find out key developments for Actelion Ltd ATLN.VX at Reuters.com, including Analyst Research at Reuters.com.

NYSE and Amex prices are delayed at least 20 minutes and Nasdaq prices are delayed at least 15 minutes. Volume updates until 8:00 p.m. ET. Real-Time Quotes

Actelion Ltd. (Swiss:ATLN) Contact Information Actelion Ltd. Gewerbestrasse 16 4123 Allschwil, Baselland, Switzerland Tel

Actelion walks a fine line. The company discovers and develops drugs based on its research of the endothelium, the single layer of cells between...

Actelion is an independent, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs. ... Actelion is an independent biopharmaceutical ...

Actelion is an independent, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs. ... 25 Nov 1999 · Actelion Ltd has established its ...

Actelion Ltd Actelion Ltd is the holding company which encompasses Actelion Pharmaceuticals Ltd, and the subsidiaries of Actelion Pharmaceuticals, headquartered in ...

Legal. Legal Statement. This web document has the sole purpose to provide members of the public with general information about the activities of Actelion Ltd and its associated ...

Actelion Enters Phase III With Novel Orexin Receptor Antagonist Almorexant Actelion Enters Phase III With Novel Orexin Receptor Antagonist Almorexant

Get the latest on Actelion Ltd (ATLN) including up to date news, high quality discussion groups and more on Google Finance.

Get the latest on ACTELION LTD (ALIOF) including up to date news, high quality discussion groups and more on Google Finance.

Access phone and fax numbers, street address and email addresses for medical information and other questions about Ventavis® inhaled prostacyclin for PAH (WHO group I).

Actelion Ltd. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly ...

THE NAPC REVIEW - Actelion Ltd. ... Mission Statement "Bring to the physician and patient innovative treatment for diseases related to endothelium through creative science?

Actelion is an independent, biopharmaceutical company discovering, developing and marketing drugs for high unmet medical needs. ... Actelion. Actelion Ltd Actelion Pharmaceuticals ...

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products. ...

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products. ...

Summary profile of lobbying by Actelion Ltd in 2004 ... NOTE: 2nd Quarter lobbying reports for 2008 were due July 21. Data will be integrated weekly into OpenSecrets.org as it is ...

Find relationships for Actelion Ltd. (ATLN) Board of Directors members. Learn about other board affiliations & connections to other executives.

Actelion Ltd.: New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential to Restore Normal Physiological Sleep in Patients Suffering From Insomnia. - ALLSCHWIL ...

Actelion Ltd: EARLY: First PAH Functional Class II Population Study Emphasizes Need to Diagnose and Treat PAH Early. - VIENNA, Austria, Sept. 3, 2007 (PRIME NEWSWIRE) -- At the ...